采用酶替代疗法治疗庞贝病的免疫调节 - Suppr

Suppr

超能文献

Immune modulation in Pompe disease treated with enzyme replacement therapy.

作者信息

Banugaria Suhrad G, Patel Trusha T, Kishnani Priya S

出版信息

Expert Rev Clin Immunol. 2012 Aug;8(6):497-9. doi: 10.1586/eci.12.40.

DOI:10.1586/eci.12.40

PMID:22992140

Abstract

摘要

相似文献

Immune modulation in Pompe disease treated with enzyme replacement therapy.采用酶替代疗法治疗庞贝病的免疫调节

Expert Rev Clin Immunol. 2012 Aug;8(6):497-9. doi: 10.1586/eci.12.40.

Enzyme therapy in Pompe disease: questions remain.

Mol Genet Metab. 2012 Sep;107(1-2):243; author reply 244. doi: 10.1016/j.ymgme.2012.05.010. Epub 2012 May 25.

New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond.庞贝病的新治疗方法：酶替代疗法及其他。

Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:114-24.

New insights into therapeutic options for Pompe disease.对庞贝病治疗选择的新见解。

IUBMB Life. 2011 Nov;63(11):979-86. doi: 10.1002/iub.529. Epub 2011 Oct 14.

Oral administration of recombinant human acid α-glucosidase reduces specific antibody formation against enzyme in mouse.口服重组人酸性 α-葡萄糖苷酶可降低小鼠针对酶的特异性抗体形成。

Mol Genet Metab. 2011 May;103(1):98-100. doi: 10.1016/j.ymgme.2011.01.009. Epub 2011 Jan 27.

Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease.庞贝病α-葡萄糖苷酶替代治疗并发肾病综合征

Pediatrics. 2004 Oct;114(4):e532-5. doi: 10.1542/peds.2003-0988-L.

High Sustained Antibody Titers in Patients with Classic Infantile Pompe Disease Following Immunomodulation at Start of Enzyme Replacement Therapy.免疫调节治疗开始时对经典婴儿型庞贝病患者进行酶替代治疗后，其抗体水平持续升高。

J Pediatr. 2018 Apr;195:236-243.e3. doi: 10.1016/j.jpeds.2017.11.046. Epub 2018 Feb 7.

Making diagnosis of Pompe disease at a presymptomatic stage: to treat or not to treat?在症状前阶段诊断庞贝氏病：治疗还是不治疗？

Neurology. 2011 Aug 9;77(6):594-5. doi: 10.1212/WNL.0b013e318228c0ea. Epub 2011 Jul 13.

Common antigenicity for two glycosidases.两种糖苷酶的共同抗原性。

FEBS Lett. 2006 Jan 9;580(1):87-92. doi: 10.1016/j.febslet.2005.11.053. Epub 2005 Dec 6.

Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease.成功诱导 CRIM 阴性婴儿庞贝病对酶替代疗法的免疫耐受。

Genet Med. 2012 Jan;14(1):135-42. doi: 10.1038/gim.2011.4.

引用本文的文献

Antibodies to recombinant human alpha-L-iduronidase prevent disease correction in cortical bone in MPS I mice.抗重组人α-L-艾杜糖醛酸酶抗体可阻止MPS I型小鼠皮质骨疾病的纠正。

Mol Ther Methods Clin Dev. 2025 Jan 2;33(1):101405. doi: 10.1016/j.omtm.2024.101405. eCollection 2025 Mar 13.

A novel CD71 Centyrin:Gys1 siRNA conjugate reduces glycogen synthesis and glycogen levels in a mouse model of Pompe disease.一种新型的CD71 Centyrin:Gys1小干扰RNA偶联物可降低庞贝病小鼠模型中的糖原合成及糖原水平。

Mol Ther. 2025 Jan 8;33(1):235-248. doi: 10.1016/j.ymthe.2024.11.033. Epub 2024 Nov 26.

Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel.婴儿型庞贝病中对阿糖苷酶的免疫应答：意大利儿科专家小组的建议。

Ital J Pediatr. 2022 Mar 5;48(1):41. doi: 10.1186/s13052-022-01219-4.

Phosphatidylserine Is Not Just a Cleanup Crew but Also a Well-Meaning Teacher.磷脂酰丝氨酸不仅是一个清理团队，也是一个善意的老师。

J Pharm Sci. 2018 Aug;107(8):2048-2054. doi: 10.1016/j.xphs.2018.03.027. Epub 2018 Apr 9.

Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease.鞘内基因治疗对庞贝病的长期神经和心脏矫正作用。

Acta Neuropathol Commun. 2017 Sep 6;5(1):66. doi: 10.1186/s40478-017-0464-2.

High dose IVIG successfully reduces high rhGAA IgG antibody titers in a CRIM-negative infantile Pompe disease patient.高剂量静脉注射免疫球蛋白成功降低了一名 CRIM 阴性婴儿型庞贝病患者的高 rhGAA IgG 抗体滴度。

Mol Genet Metab. 2017 Sep;122(1-2):76-79. doi: 10.1016/j.ymgme.2017.05.006. Epub 2017 May 18.

Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe disease.非耗竭性抗CD4单克隆抗体在庞贝病小鼠模型中诱导对酶替代疗法的免疫耐受。

Mol Genet Metab Rep. 2014 Oct 12;1:446-450. doi: 10.1016/j.ymgmr.2014.08.005. eCollection 2014.

Alglucosidase alfa treatment alleviates liver disease in a mouse model of glycogen storage disease type IV.阿糖苷酶α治疗可缓解IV型糖原贮积病小鼠模型中的肝脏疾病。

Mol Genet Metab Rep. 2016 Oct 4;9:31-33. doi: 10.1016/j.ymgmr.2016.09.008. eCollection 2016 Dec.

Durable and sustained immune tolerance to ERT in Pompe disease with entrenched immune responses.在庞贝病中，对酶替代疗法（ERT）产生持久且持续的免疫耐受，伴有顽固的免疫反应。

JCI Insight. 2016 Jul 21;1(11). doi: 10.1172/jci.insight.86821.

Phosphatidylserine Converts Immunogenic Recombinant Human Acid Alpha-Glucosidase to a Tolerogenic Form in a Mouse Model of Pompe Disease.在庞贝病小鼠模型中，磷脂酰丝氨酸将免疫原性重组人酸性α-葡萄糖苷酶转化为耐受性形式。

J Pharm Sci. 2016 Oct;105(10):3097-3104. doi: 10.1016/j.xphs.2016.06.018. Epub 2016 Jul 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验